a2 Milk Co. Secures Final China Approval for Infant Formula Transfer
MT Newswires Live
Jun 22
a2 Milk Co. (ASX:A2M, NZE:ATM) received approval from China's State Administration for Market Regulation to transfer two China-label infant milk formula registrations tied to its Pokeno facility to its a2 brand, according to a Monday filing with the New Zealand bourse.
The company confirmed that the acquisition of the a2 Pokeno facility is now irrevocable, given the receipt of all required regulatory approvals, per the filing.
The board is expected to meet soon to consider a NZ$300 million fully franked special dividend, with timing and details to be released upon formal approval, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.